Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.

PURPOSE Increased local production of matrix metalloproteinases (MMPs) is a potential mechanism underlying structural protein degradation in abdominal aortic aneurysms (AAA). With an elastase-induced rodent model of AAA, we determined whether pharmacologic treatment with an MMP-inhibiting tetracycline might limit the development of experimental AAA in vivo. METHODS Forty-eight Wistar rats underwent a 2-hour perfusion of the abdominal aorta with 50 U porcine pancreatic elastase and were then treated with either subcutaneous doxycycline (25 mg/day; n=24) or saline solution vehicle (n=24). Aortic diameter was measured before and after elastase perfusion was performed and before the rats were killed at 0, 2, 7, or 14 days, and AAAs were defined as an increase in aortic diameter to at least twice that before perfusion. At death the aortic tissues were either perfusion-fixed for histologic evaluation or extracted for substrate zymographic evaluation. RESULTS Aortic diameter was not different between groups at 0 or 2 days, but it was significantly less in animals treated with doxycycline at both 7 and 14 days (mean+/-SEM, p<0.01). After day 2 the incidence of AAA was reduced from 83% (10 of 12 rats treated with saline solution) to 8% (1 of 12 animals treated with doxycycline). By histologic assessment doxycycline prevented the structural deterioration of aortic elastin without decreasing the influx of inflammatory cells. Increased aortic wall production of 92 kD gelatinase observed in a saline solution-treated control group was markedly suppressed in animals treated with doxycycline. CONCLUSIONS Treatment with an MMP-inhibiting tetracycline inhibits the development of experimental AAA in vivo. This inhibition may be due to selective blockade of elastolytic MMP expression in infiltrating inflammatory cells. Additional experiments, however, are necessitated to fully delineate this process.

[1]  R. Mecham,et al.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. , 1995, The Journal of clinical investigation.

[2]  D. Loskutoff,et al.  Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. , 1995, The Journal of clinical investigation.

[3]  C. Brophy,et al.  Characterization of an elastase from aneurysmal aorta which degrades intact aortic elastin , 1992, Annals of vascular surgery.

[4]  W. Pearce,et al.  In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. , 1995, Journal of vascular surgery.

[5]  T. Ley,et al.  Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. , 1993, The Journal of biological chemistry.

[6]  R. Laskin,et al.  Inhibition of epiphyseal cartilage collagenase by tetracyclines in low phosphate rickets in rats , 1988, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  J. Michel,et al.  Elastase-induced experimental aneurysms in rats. , 1990, Circulation.

[8]  S. Katsuda,et al.  An elastinolytic enzyme detected in the culture medium of human arterial smooth muscle cells , 1993, Cell biology international.

[9]  R. Stoney,et al.  Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  J. Scholes,et al.  Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. , 1993, The Journal of surgical research.

[11]  R. Greenwald Treatment of Destructive Arthritic Disorders with MMP Inhibitors , 1994, Annals of the New York Academy of Sciences.

[12]  W. Pearce,et al.  Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. , 1990, The American journal of pathology.

[13]  J Ochsner,et al.  Recommended indications for operative treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the Society for Vascular Surgery and the North American Chapter of the International Society for Cardiovascular Surgery. , 1992, Journal of vascular surgery.

[14]  W. Parks,et al.  Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. , 1995, Journal of vascular surgery.

[15]  G. Chejfec,et al.  Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. , 1992, Journal of vascular surgery.

[16]  C. Brophy,et al.  The role of inflammation in nonspecific abdominal aortic aneurysm disease , 1991, Annals of vascular surgery.

[17]  J. S. Yao,et al.  Collagen types and matrix protein content in human abdominal aortic aneurysms. , 1989, Journal of vascular surgery.

[18]  A. Eisen,et al.  Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. , 1990, The Journal of clinical investigation.

[19]  G. Sicard,et al.  Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. , 1994, Journal of vascular surgery.

[20]  M. Reidy,et al.  Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. , 1994, Circulation research.

[21]  W. Pearce,et al.  In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[22]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[23]  L. Matrisian,et al.  Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.

[24]  J. Scholes,et al.  The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response. , 1994, Journal of vascular surgery.

[25]  J. Scholes,et al.  Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources. , 1994, Connective tissue research.

[26]  E. Kieffer,et al.  Pathogenesis of acquired aneurysms of the abdominal aorta , 1992, Annals of vascular surgery.

[27]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  M. Cockett,et al.  Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). , 1991, The Biochemical journal.

[29]  J. Powell,et al.  Metalloproteinases in degenerative aortic disease. , 1991, Clinical science.

[30]  S. Shapiro,et al.  Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.

[31]  L. Golub,et al.  Doxycycline and Chemically Modified Tetracyclines Inhibit Gelatinase A (MMP‐2) Gene Expression in Human Skin Keratinocytes , 1994, Annals of the New York Academy of Sciences.

[32]  H. M. Lee,et al.  Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. , 1983, Journal of periodontal research.

[33]  J. Cohen,et al.  Smooth muscle cell elastase, atherosclerosis, and abdominal aortic aneurysms. , 1992, Annals of surgery.

[34]  B. Sumpio,et al.  Electrophoretic characterization of protease expression in aneurysmal aorta : report of a unique 80kDa elastolytic activity , 1991 .

[35]  H. Nagase,et al.  Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  H. M. Lee,et al.  A Non‐Antimicrobial Tetracycline Inhibits Gingival Matrix Metalloproteinases and Bone Loss in Porphyromonas gingivalis‐induced Periodontitis in Rats a , 1994, Annals of the New York Academy of Sciences.

[37]  L. Golub,et al.  Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. , 1992, The Journal of rheumatology.

[38]  J. Scholes,et al.  Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. , 1994, Journal of vascular surgery.

[39]  Janet T. Powell,et al.  The Cause and Management of Aneurysms , 1990 .

[40]  M. D. Tilson,et al.  Analysis of elastin cross-linking and the connective tissue matrix of abdominal aortic aneurysms. , 1994, Surgery.